Our team of experts brings you cancer-related news, features, and survivor stories.
For the latest news about research we conduct and fund, see ACS Research News.
Published on: March 31, 2020
Phyllis Alsterberg was recently treated for non-Hodgkin lymphoma. She hasn’t left her home in New York City much since the coronavirus outbreak started because she has a weakened immune system and she’s worried about getting sick.
Published on: June 28, 2019
When Crystal Zunino was diagnosed with non-Hodgkin lymphoma in January 2015, she was just half-way through her first year as a new middle-school math teacher in Warner Robins, Georgia.
Published on: June 12, 2019
The US Food and Drug Administration (FDA) has approved the antibody-drug conjugate Polivy (polatuzumab vedotin-piiq) to treat people with diffuse large B-cell lymphoma (DLBCL).
Published on: December 6, 2018
The US Food and Drug Administration (FDA) has approved Truxima (rituximab-abbs), the first biosimilar drug to treat adults with some types of non-Hodgkin lymphoma.
